Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering
Irvine, CA, & Cincinnati, OH — February 23, 2022 – Boustead Securities, LLC (“Boustead”) IPO client Blue Water Vaccines Inc. ("BWV" or...
Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering
Boustead IPO Client HeartCore Enterprises, Inc. Announces Closing of $15.0 Million Nasdaq IPO
Boustead Client HeartCore Enterprises, Inc. ("HTCR") Announces Pricing of $15.0 Million IPO
Boustead Client Newt Signs Agreement with Element Bank for its Digital Lending Program in Mexico
Cytta (CYCA) Engages Boustead Securities as Exclusive Financial Advisor
Mainz Biomed Announces Pricing of $22.5m Follow-on Offering
Boustead Client Cerberus Sentinel (CISO) Announces Uplisting to Nasdaq
Boustead Securities’ Client, The Messi Store, Conducts Initial Private Placement Closing
EV Dynamics Announces Filing of SEC Registration Statement for Proposed NASDAQ IPO